153 related articles for article (PubMed ID: 32409701)
1. Development of Small Molecule MEIS Inhibitors that modulate HSC activity.
Turan RD; Albayrak E; Uslu M; Siyah P; Alyazici LY; Kalkan BM; Aslan GS; Yucel D; Aksoz M; Tuysuz EC; Meric N; Durdagi S; Gulbas Z; Kocabas F
Sci Rep; 2020 May; 10(1):7994. PubMed ID: 32409701
[TBL] [Abstract][Full Text] [Related]
2. Lead Optimization and Structure-Activity Relationship Studies on Myeloid Ecotropic Viral Integration Site 1 Inhibitor.
Turgutalp B; Uslu M; Helvacioglu S; Charehsaz M; Gurdal EE; Sippl W; Kocabas F; Yarim M
J Med Chem; 2021 Oct; 64(19):14448-14464. PubMed ID: 34542289
[TBL] [Abstract][Full Text] [Related]
3. Newly developed MEIS inhibitor selectively blocks MEIS
Girgin B; Kocabaş F
Gene; 2023 Jun; 871():147425. PubMed ID: 37044182
[TBL] [Abstract][Full Text] [Related]
4. MEIS inhibitors reduce the viability of primary leukemia cells and Stem cells by inducing apoptosis.
Meriç N; Albayrak E; Gülbaş Z; Kocabaş F
Leuk Lymphoma; 2024 Feb; 65(2):187-198. PubMed ID: 37902585
[TBL] [Abstract][Full Text] [Related]
5. c-Myc Inhibitor 10074-G5 Induces Murine and Human Hematopoietic Stem and Progenitor Cell Expansion and HDR Modulator Rad51 Expression.
Aksoz M; Albayrak E; Aslan GS; Turan RD; Alyazici LY; Siyah P; Tuysuz EC; Canikyan S; Yucel D; Meric N; Gulbas Z; Sahin F; Kocabas F
Curr Cancer Drug Targets; 2019; 19(6):479-494. PubMed ID: 30182856
[TBL] [Abstract][Full Text] [Related]
6. Meis1 regulates the metabolic phenotype and oxidant defense of hematopoietic stem cells.
Kocabas F; Zheng J; Thet S; Copeland NG; Jenkins NA; DeBerardinis RJ; Zhang C; Sadek HA
Blood; 2012 Dec; 120(25):4963-72. PubMed ID: 22995899
[TBL] [Abstract][Full Text] [Related]
7. Emerging Roles of Meis1 in Cardiac Regeneration, Stem Cells and Cancer.
Aksoz M; Turan RD; Albayrak E; Kocabas F
Curr Drug Targets; 2018; 19(2):181-190. PubMed ID: 28745213
[TBL] [Abstract][Full Text] [Related]
8. HOXB13 interaction with MEIS1 modifies proliferation and gene expression in prostate cancer.
Johng D; Torga G; Ewing CM; Jin K; Norris JD; McDonnell DP; Isaacs WB
Prostate; 2019 Mar; 79(4):414-424. PubMed ID: 30560549
[TBL] [Abstract][Full Text] [Related]
9. MEIS-mediated suppression of human prostate cancer growth and metastasis through HOXB13-dependent regulation of proteoglycans.
VanOpstall C; Perike S; Brechka H; Gillard M; Lamperis S; Zhu B; Brown R; Bhanvadia R; Vander Griend DJ
Elife; 2020 Jun; 9():. PubMed ID: 32553107
[TBL] [Abstract][Full Text] [Related]
10. MEIS1 and its potential as a cancer therapeutic target (Review).
Yao M; Gu Y; Yang Z; Zhong K; Chen Z
Int J Mol Med; 2021 Sep; 48(3):. PubMed ID: 34318904
[TBL] [Abstract][Full Text] [Related]
11. Myeloid ecotropic viral integration site 1 (MEIS) 1 involvement in embryonic implantation.
Xu B; Geerts D; Qian K; Zhang H; Zhu G
Hum Reprod; 2008 Jun; 23(6):1394-406. PubMed ID: 18408019
[TBL] [Abstract][Full Text] [Related]
12. Meis1 Is Required for Adult Mouse Erythropoiesis, Megakaryopoiesis and Hematopoietic Stem Cell Expansion.
Miller ME; Rosten P; Lemieux ME; Lai C; Humphries RK
PLoS One; 2016; 11(3):e0151584. PubMed ID: 26986211
[TBL] [Abstract][Full Text] [Related]
13. MEIS C termini harbor transcriptional activation domains that respond to cell signaling.
Huang H; Rastegar M; Bodner C; Goh SL; Rambaldi I; Featherstone M
J Biol Chem; 2005 Mar; 280(11):10119-27. PubMed ID: 15654074
[TBL] [Abstract][Full Text] [Related]
14. Enhanced self-renewal of hematopoietic stem/progenitor cells mediated by the stem cell gene Sall4.
Yang J; Aguila JR; Alipio Z; Lai R; Fink LM; Ma Y
J Hematol Oncol; 2011 Sep; 4():38. PubMed ID: 21943195
[TBL] [Abstract][Full Text] [Related]
15. Range of HOX/TALE superclass associations and protein domain requirements for HOXA13:MEIS interaction.
Williams TM; Williams ME; Innis JW
Dev Biol; 2005 Jan; 277(2):457-71. PubMed ID: 15617687
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of histone deacetylases promote hematopoietic stem cell self-renewal.
Young JC; Wu S; Hansteen G; Du C; Sambucetti L; Remiszewski S; O'Farrell AM; Hill B; Lavau C; Murray LJ
Cytotherapy; 2004; 6(4):328-36. PubMed ID: 16146885
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia and metabolic properties of hematopoietic stem cells.
Zhang CC; Sadek HA
Antioxid Redox Signal; 2014 Apr; 20(12):1891-901. PubMed ID: 23621582
[TBL] [Abstract][Full Text] [Related]
18. MEIS1 and MEIS2 Expression and Prostate Cancer Progression: A Role For HOXB13 Binding Partners in Metastatic Disease.
Bhanvadia RR; VanOpstall C; Brechka H; Barashi NS; Gillard M; McAuley EM; Vasquez JM; Paner G; Chan WC; Andrade J; De Marzo AM; Han M; Szmulewitz RZ; Vander Griend DJ
Clin Cancer Res; 2018 Aug; 24(15):3668-3680. PubMed ID: 29716922
[No Abstract] [Full Text] [Related]
19. The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche.
Simsek T; Kocabas F; Zheng J; Deberardinis RJ; Mahmoud AI; Olson EN; Schneider JW; Zhang CC; Sadek HA
Cell Stem Cell; 2010 Sep; 7(3):380-90. PubMed ID: 20804973
[TBL] [Abstract][Full Text] [Related]
20. Linkage of the potent leukemogenic activity of Meis1 to cell-cycle entry and transcriptional regulation of cyclin D3.
Argiropoulos B; Yung E; Xiang P; Lo CY; Kuchenbauer F; Palmqvist L; Reindl C; Heuser M; Sekulovic S; Rosten P; Muranyi A; Goh SL; Featherstone M; Humphries RK
Blood; 2010 May; 115(20):4071-82. PubMed ID: 20237320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
